Neuromyelitis optica and myasthenia gravis in a young Nigerian girl

BMJ Case Reports
Salisu Abdullahi BalarabeNma Jiya

Abstract

Neuromyelitis optica (NMO) and myasthenia gravis (MG) are rare autoimmune disorders. The coexistence of the two disorders, although rare, has been documented. This is a case report of a 16-year-old student who presented with recurrent episodes of transverse myelitis and optic neuritis, 8 years after diagnosis of MG. She presented with visual impairment, relapsing and remitting weakness, numbness and paraesthesia of her lower limbs, with bladder and bowel incontinence. Her examination revealed bilateral optic atrophy, spastic paraparesis of the lower limbs and patchy sensory loss up to thoracic level (T4-5). She had a positive acetylcholine receptor antibody, a positive aquaporin-4 antibody and chest CT finding of thymic enlargement. We therefore confirmed the previous diagnosis of MG and performed a recent diagnosis of background NMO. A high index of suspicion is needed to make a diagnosis of this rare coexistence of NMO and MG in resource-limited settings such as Nigeria.

Citations

Jan 24, 2018·World Journal of Diabetes·Victoria A Serhiyenko, Alexandr A Serhiyenko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Y FurukawaM Yamada
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Li-Li NieGuan-Fang Su
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Silje Agnethe Stokke KvistadChristian A Vedeler
© 2021 Meta ULC. All rights reserved